See more : Mediaset España Comunicación, S.A. (GETVY) Income Statement Analysis – Financial Results
Complete financial analysis of Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bharat Immunologicals & Biologicals Corporation Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Tian Shan Development (Holding) Limited (2118.HK) Income Statement Analysis – Financial Results
- Nekkar ASA (NKR.OL) Income Statement Analysis – Financial Results
- RBC Life Sciences, Inc. (RBCL) Income Statement Analysis – Financial Results
- eMedia Holdings Limited (EMH.JO) Income Statement Analysis – Financial Results
- G. Willi-Food International Ltd. (WILC.TA) Income Statement Analysis – Financial Results
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
About Bharat Immunologicals & Biologicals Corporation Limited
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 446.09M | 783.88M | 853.34M | 668.37M | 836.46M | 347.99M | 1.24B | 1.28B | 1.46B | 2.03B | 1.73B | 463.42M | 25.52M | 28.37M | 71.08M | 134.85M |
| Cost of Revenue | 592.77M | 660.47M | 883.50M | 619.21M | 796.88M | 299.07M | 974.41M | 1.19B | 1.26B | 1.70B | 1.51B | 346.88M | 19.22M | 5.29M | 55.59M | 109.29M |
| Gross Profit | -146.68M | 123.41M | -30.16M | 49.16M | 39.58M | 48.92M | 267.44M | 89.03M | 202.29M | 331.26M | 220.98M | 116.54M | 6.30M | 23.09M | 15.49M | 25.56M |
| Gross Profit Ratio | -32.88% | 15.74% | -3.53% | 7.35% | 4.73% | 14.06% | 21.54% | 6.95% | 13.83% | 16.34% | 12.79% | 25.15% | 24.69% | 81.37% | 21.79% | 18.95% |
| Research & Development | 0.00 | 5.00K | 4.80M | 5.22M | 5.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.37M | 1.55M | 1.35M | 1.75M | 1.28M | 1.80M | 2.71M | 37.40M | 72.65M | 100.40M | 0.00 | 12.53M | 5.17M | 390.00K | 590.00K | 691.00K |
| Selling & Marketing | 3.51M | 4.95M | 5.70M | 5.55M | 7.09M | 2.93M | 7.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.88M | 6.50M | 7.05M | 7.30M | 8.37M | 4.73M | 10.49M | 37.40M | 72.65M | 100.40M | 0.00 | 12.53M | 5.17M | 390.00K | 590.00K | 691.00K |
| Other Expenses | -109.00K | 234.00K | 256.00K | 368.00K | 564.00K | 278.00K | 686.00K | 567.00K | 909.00K | 3.80M | 2.65M | 233.00K | 7.74M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 24.01M | 171.95M | 180.82M | 154.40M | 133.72M | 132.34M | 144.90M | 145.03M | 177.90M | 199.86M | 141.31M | 72.88M | 59.22M | 76.62M | 53.10M | 84.64M |
| Cost & Expenses | 607.56M | 832.42M | 1.06B | 773.61M | 930.60M | 431.41M | 1.12B | 1.34B | 1.44B | 1.90B | 1.65B | 419.76M | 78.43M | 81.91M | 108.69M | 193.93M |
| Interest Income | 4.62M | 5.48M | 6.84M | 9.13M | 7.23M | 9.66M | 9.37M | 13.35M | 6.39M | 3.89M | 1.14M | 4.11M | 3.72M | 5.13M | 0.00 | 0.00 |
| Interest Expense | 70.41M | 51.09M | 43.64M | 40.63M | 14.57M | 8.26M | 27.07M | 18.16M | 5.87M | 44.43M | 1.88M | 4.09M | 337.90K | 0.00 | 0.00 | 84.00K |
| Depreciation & Amortization | 2.00M | 2.13M | 2.37M | 2.37M | 2.76M | 4.14M | 5.76M | 6.46M | 9.12M | 10.37M | 12.58M | 12.36M | 13.70M | 15.57M | 17.76M | 14.71M |
| EBITDA | -151.05M | -38.83M | -191.94M | -92.25M | -50.94M | -67.25M | 132.13M | -64.96M | 40.87M | 133.45M | 89.52M | 72.85M | -39.22M | -20.10M | -17.83M | -44.49M |
| EBITDA Ratio | -33.86% | -5.20% | -23.67% | -14.82% | -6.74% | -20.46% | 9.93% | -5.07% | 2.46% | 8.08% | 4.61% | 13.14% | -153.71% | -115.73% | -27.93% | -32.90% |
| Operating Income | -160.07M | -48.64M | -211.20M | -106.04M | -95.94M | -85.32M | 93.86M | -90.15M | 20.02M | 106.29M | 66.09M | 59.36M | -49.53M | -35.67M | -35.59M | -59.28M |
| Operating Income Ratio | -35.88% | -6.21% | -24.75% | -15.86% | -11.47% | -24.52% | 7.56% | -7.04% | 1.37% | 5.24% | 3.82% | 12.81% | -194.12% | -125.74% | -50.07% | -43.96% |
| Total Other Income/Expenses | -62.61M | -48.34M | -31.10M | -36.79M | 20.40M | 3.83M | -29.81M | -37.88M | -17.24M | -21.38M | 2.65M | 16.32M | 7.74M | 0.00 | -777.39K | 0.00 |
| Income Before Tax | -222.68M | -96.87M | -242.08M | -142.03M | -73.74M | -79.59M | 92.23M | -89.58M | 20.93M | 110.10M | 68.73M | 59.60M | -41.79M | -35.67M | -35.59M | -59.28M |
| Income Before Tax Ratio | -49.92% | -12.36% | -28.37% | -21.25% | -8.82% | -22.87% | 7.43% | -7.00% | 1.43% | 5.43% | 3.98% | 12.86% | -163.79% | -125.74% | -50.07% | -43.96% |
| Income Tax Expense | -56.29M | -9.34M | -60.95M | -39.92M | -15.80M | -36.97M | 27.12M | -27.49M | 5.47M | 46.03M | 18.58M | -66.04M | -3.38M | 52.21M | 1.28M | -19.27M |
| Net Income | -166.39M | -87.54M | -181.13M | -102.11M | -57.93M | -42.62M | 65.10M | -62.09M | 15.46M | 64.07M | 50.15M | 125.64M | -41.79M | -87.89M | -35.23M | -40.01M |
| Net Income Ratio | -37.30% | -11.17% | -21.23% | -15.28% | -6.93% | -12.25% | 5.24% | -4.85% | 1.06% | 3.16% | 2.90% | 27.11% | -163.79% | -309.77% | -49.57% | -29.67% |
| EPS | -3.85 | -2.03 | -4.19 | -2.36 | -1.34 | -0.99 | 1.51 | -1.44 | 0.36 | 1.48 | 1.16 | 2.91 | -0.97 | -2.04 | -0.82 | -0.93 |
| EPS Diluted | -3.85 | -2.03 | -4.19 | -2.36 | -1.34 | -0.99 | 1.51 | -1.44 | 0.36 | 1.48 | 1.16 | 2.91 | -0.97 | -2.04 | -0.82 | -0.93 |
| Weighted Avg Shares Out | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 42.97M | 43.03M |
| Weighted Avg Shares Out (Dil) | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 43.18M | 42.97M | 43.03M |
Source: https://incomestatements.info
Category: Stock Reports